Clinical Trial Update: Adrenal Artery Ablation for Primary Aldosteronism [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial update on adrenal artery ablation for primary aldosteronism and hypertension is ongoing, with status currently unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aldosteronism
• Hypertension

Snippet

Sponsor: Third Military Medical University | Conditions: Primary Aldosteronism, Hypertension | Phase 3 | Status: UNKNOWN